← Back to Patent Explorer
US4550168A Expired / Lapsed US ⏱️ 0.0 years remaining

Benzisoselenazolones and a process for the treatment of inflammatory diseases

Assignee: A NATTERMANN & CIE NATTERMANNALLEE 1 D-5000 COLOGNE 30 GmbH
•
Filing: 1983-07-12
•
Granted: 1985-10-29
•
Expires: 2003-07-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to new benzisoselenazolones of the general formula I ##STR1## and a process for the treatment of humans suffering from inflammatory diseases of the rheumatic type.

Inventors

  • 👤 Andre Welter
  • 👤 Sigurd Leyck
  • 👤 Eugen Etschenberg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 12:55
CPC Classifications
C; C07; C07D; C07D421/00; C07D421/02; C07D421/04; A; A61; A61P; A61P29/00

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 100 words
Benzisoselenazolones of the formula I ##STR4## wherein R 1 and R 2 which can be the same or different from each other, are selected from the group consisting of hydrogen, halogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, hydroxyl, trifluoromethyl, nitro, di-(C 1 -C 4 -alkyl)-amino and R 1 and R 2 together, methylenedioxy, and R 3 is a member selected from the group consisting of the heterocyclic group pyridyl, and such heterocyclic group substituted once or twice, identically or differently, by halogen, C 1 -C 2 -alkyl, C 1 -C 4 -alkoxy, hydroxyl, nitro, and carboxyl.
Claim 2
Dependent Claim 100 words
Benzisoselenazolones of the formula I ##STR4## wherein R 1 and R 2 which can be the same or different from each other, are selected from the group consisting of hydrogen, halogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, hydroxyl, trifluoromethyl, nitro, di-(C 1 -C 4 -alkyl)-amino and R 1 and R 2 together, methylenedioxy, and R 3 is a member selected from the group consisting of the heterocyclic group pyridyl, and such heterocyclic group substituted once or twice, identically or differently, by halogen, C 1 -C 2 -alkyl, C 1 -C 4 -alkoxy, hydroxyl, nitro, and carboxyl.
Claim 3
Dependent Claim 83 words
Benzisoselenazolones according to claim 1, wherein R 1 and R 2 which can be identical or different from each other, are members selected from the group consisting of hydrogen, fluorine, chlorine, bromine, hydroxyl, methoxy, trifluoromethyl, nitro and, R 1 and R 2 together, methylendioxy, and R 3 is a member selected from the group consisting of the cyclic group pyridyl, and such heterocyclic group substituted once or twice, identically or differently, by fluorine, chlorine, bromine, methyl, ethyl, butyl, methoxy, ethoxy, hydroxyl, nitro, carboxyl.
Claim 4
Dependent Claim 77 words
Benzisoselenazolones according to claim 1, wherein R 1 and R 2 which can be identical or different from each other are selected from the group consisting of hydrogen, chlorine, methyl, methoxy, nitro and R 1 and R 2 together, methylenedioxy, and R 3 is a member selected from the group consisting of the heterocyclic group, pyridyl, and such heterocyclic group substituted once or twice, identically or differently, by fluorine, chlorine, bromine, methyl, methoxy, ethoxy, hydroxyl, nitro, carboxyl.
Claim 5
Dependent Claim 1 words
2-(2-Pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 6
Dependent Claim 1 words
2-(2-Pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 7
Dependent Claim 1 words
2-(3-Pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 8
Dependent Claim 1 words
2-(3-Pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 9
Dependent Claim 1 words
2-(4-Pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 10
Dependent Claim 1 words
2-(4-Pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 11
Dependent Claim 1 words
2-(2-Chloro-3-pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 12
Dependent Claim 1 words
2-(2-Chloro-3-pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 13
Dependent Claim 1 words
2-(2,6-Dichloro-3-pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 14
Dependent Claim 1 words
2-(2,6-Dichloro-3-pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 15
Dependent Claim 1 words
2-(6-Methoxy-3-pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 16
Dependent Claim 1 words
2-(6-Methoxy-3-pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 17
Dependent Claim 1 words
2-(5-Chloro-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 18
Dependent Claim 1 words
2-(5-Chloro-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 19
Dependent Claim 1 words
2-(4,6-Dimethyl-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one.
Claim 20
Dependent Claim 1 words
2-(4,6-Dimethyl-2-pyridyl)-1,2-benzisoselenazol-3(2H)-one.

References Cited (Backward Citations)

US2933432A Cited
US3012039A Cited
US4243669A Cited
US4156729A Cited
DE3027075A1 Cited
DE3027074A1 Cited
US4418069A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-10-28 1989-04-29 1989-10-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-10-28 1993-04-29 1993-10-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-10-28 1997-04-29 1997-10-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag